Anyone know what multiples are popular for valuation of insurers, specifically conglomerate-types (i.e. Allstate, State Farm, etc.)?
Wasn't sure if P/BV or P/TBV were favored over EV/EBITDA or any other metrics.
Thanks in advance.
Trending Content
| +145 | How to stop feeling like shit for not making it in IB? | 55 | 3h | |
| +108 | If Tik Tok is forced to sell, what banks do you think would be involved in the deal? | 53 | 13m | |
| +67 | Updated LA Banking Scene (2024) | 49 | 12h | |
| +38 | Ranking banks that went under | 20 | 2s | |
| +32 | A strategy for SA applicants late to the game like myself | 15 | 6h | |
| +32 | Burnt Out M&A ASO | 17 | 3h | |
| +31 | UBS Actual Buyside Exits 2024 Post-Integration | 9 | 3d | |
| +29 | Relevance of A-Levels for U.K. London recruiting | 21 | 13h | |
| +26 | Series 79 Help / Tips to Pass The First Attempt | 11 | 1d | |
| +25 | Intern Ettiquette | 4 | 9h |
Career Resources
I'll preface this by saying that insurers are pretty hard to value correctly, and you shouldn't use one multiple (or even a set of multiples). Like diversified banks, they incredibly complex. But, if you are looking for some quick metrics:
Price to Book, excluding accumulated other comprehensive income. Run that against ROE (based on operating EPS; GAAP net income is not a great representation of earnings) to get a regression.
Also look at more ordinary measures such as P/FCF, P/E, etc. Looking at underwriting ratios (e.g. the Combined Ratio) is important for both, but more for P&C due to its decreased reliance on investment income.
For Life Insurers, also look as Risk Based Capital ratios, excess capital, product mix, portfolio vs product durations, etc. Life insurers are very sensitive to interest rates; interest rate movement will affect their earnings and multiples.
For P&C, look at Incurred but not Reported claim to Net Reserves, where the industry is with regards to the pricing cycle (P&C is cyclical), geographic distribution, and seasonality.
I assume you are not interested in bond or mortgage insurers; they have their own valuation methodologies.
Correct, more of the standard industry players that offer Life, P&C, and other types of insurance.
In markets outside the US most Life Insurance companies trade around a multiple of (or discount to) embedded value. This is almost like a book value for the insurance company as it adds the discounted profits expected to emerge from the current book of policy holders to the NAV for the shareholder funds. There is also MCEV and European EV which differ.
I think US insurers might trade off earnings multiples but EV reporting is becoming more important. Not really sure on the US market though. Hope this helps
I those are P&C companies then it is more an EBITDA type business and embedded value does not apply. Underwriting margins and income earned on the float would be important
Tempore non eius repudiandae quos omnis est eos. Doloremque esse tempore laboriosam. Quibusdam velit eum temporibus sint consequuntur magnam.
Blanditiis quae adipisci molestiae pariatur. Et ducimus blanditiis omnis porro voluptatem maxime id earum.
Accusantium tenetur qui velit et totam quaerat. Quia porro quia saepe sed. Voluptas sunt quas rerum nostrum error repellat. Est dolor eum quis et.
Neque molestiae tempore earum nostrum. Eaque non est consectetur ab necessitatibus quibusdam. Eligendi amet illo enim molestiae quia. A veniam dolor aliquam dolorem hic doloremque.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...